Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 30: 1512-1516, 1984;
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amiral, J.
Right arrow Articles by Adam, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amiral, J.
Right arrow Articles by Adam, M.

Clinical Chemistry, Vol 30, 1512-1516, Copyright © 1984 by American Association for Clinical Chemistry

Application of enzyme immunoassays to coagulation testing

J Amiral, B Adalbert and M Adam

Enzyme immunoassays are very useful for the detection of low concentrations of coagulation proteins and pathological markers in plasma. Analytes in the ng/mL range are measurable with good reproducibility with intra- and interassay CVs of less than 5% to 10%. "Sandwich" methods have been developed for von Willebrand factor (plasma concentration about 8 micrograms/mL, Factor IX (5 micrograms/mL), protein C (4 micrograms/mL), and Factor X (10 micrograms/mL). However, this technique is only suitable for macromolecules; for low-molecular-mass peptides such as fibrinopeptide A a competitive method is used. Normal concentrations of fibrinopeptide A are below 3 ng/mL, with greater values suggesting in vivo generation of thrombin; thus this test is quite useful in detecting thrombosis. Reagents for both the sandwich and competitive methods are commercially available and cost effective, and have a longer shelf-life than those for radioimmunoassays.


The following articles in journals at HighWire Press have cited this article:


Home page
CLIN APPL THROMB HEMOSTHome page
J. Fareed, J. M. Walenga, D. A. Hoppensteadt, W. P. Jeske, S. Ahmad, H. Lietz, R. McKenna, H. L. Messmore, and S. Haas
Soluble Adhesion Molecules in the HIT Syndrome: Pathophysiologic Role and Therapeutic Modulation
Clinical and Applied Thrombosis/Hemostasis, October 1, 1999; 5(1_suppl): S38 - S44.
[Abstract] [PDF]


Home page
CLIN APPL THROMB HEMOSTHome page
J. Fareed, D. A. Hoppensteadt, F. Leya, B. Lewis, D. Callas, H. Wolf, and R. L. Bick
State-of-the-Art-Review : Thrombogenesis in Myocardial Infarction and Related Syndromes: The Role of Molecular Markers in Diagnosis and Management
Clinical and Applied Thrombosis/Hemostasis, April 1, 1999; 5(2): 78 - 91.
[PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. P. Wamala, M. A. Murray, M. Horsten, M. Eriksson, K. Schenck-Gustafsson, A. Hamsten, A. Silveira, and K. Orth-Gomer
Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 485 - 492.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. Fareed, D. A. Hoppensteadt, F. Leya, O. Iqbal, H. Wolf, and R. Bick
Useful laboratory tests for studying thrombogenesis in acute cardiac syndromes
Clin. Chem., August 1, 1998; 44(8): 1845 - 1853.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Lopez-Segura, F. Velasco, J. Lopez-Miranda, P. Castro, R. Lopez-Pedrera, A. Blanco, J. Jimenez-Pereperez, A. Torres, J. Trujillo, J.M. Ordovas, et al.
Monounsaturated Fatty Acid–Enriched Diet Decreases Plasma Plasminogen Activator Inhibitor Type 1
Arterioscler Thromb Vasc Biol, January 1, 1996; 16(1): 82 - 88.
[Abstract] [Full Text]


Home page
CLIN APPL THROMB HEMOSTHome page
J. Fareed, R. L. Bick, D. A. Hoppensteadt, and E. W. Bermes
Molecular Markers of Hemostatic Activation: Applications in the Diagnosis of Thrombosis and Vascular and Thrombotic Disorders
Clinical and Applied Thrombosis/Hemostasis, March 1, 1995; 1(2): 87 - 102.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by the American Association for Clinical Chemistry.